Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Pathogenesis of non-Hodgkin's lymphomaHendrik Nogai, Bernd Dörken, Georg Lenz
Case Reports in Hematology|August 29, 2013
Improvement of paraneoplastic limbic encephalitis after systemic treatment with rituximab in a patient with B-cell chronic lymphocytic leukemiaHendrik Nogai, Heike Israel-Willner, Rolf Zschenderlein, et al.
Cells|October 14, 2022
Patient Selection Approaches in FGFR Inhibitor Trials-Many Paths to the Same End?Peter Ellinghaus, Daniel Neureiter, Hendrik Nogai, et al.
Biomarker Insights|September 18, 2015
BCR-ABL Mutation-Guided Therapy for CML Blast Crisis: A Case ReportBenjamin N Ostendorf, Hendrik Nogai, Claudia D Baldus, et al.
Differentiation; Research in Biological Diversity|November 22, 2007
Follistatin antagonizes transforming growth factor-beta3-induced epithelial-mesenchymal transition in vitro: implications for murine palatal development supported by microarray analysisHendrik Nogai, Mark Rosowski, Joachim Grün, et al.
Haematologica|December 18, 2009
Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemiaTheo D Kim, Seval Türkmen, Michaela Schwarz, et al.
Springerplus|July 15, 2014
Synchronous tuberculosis, Epstein-Barr virus-associated lymphoproliferative disorder and cytomegalovirus infection in an allogeneic transplant recipient: a case reportBenjamin Nils Ostendorf, Christian Friedrich Jehn, Lam Giang Vuong, et al.
Thyroid : Official Journal of the American Thyroid Association|October 9, 2010
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemiaTheo D Kim, Michaela Schwarz, Hendrik Nogai, et al.
Targeted Oncology|June 4, 2025
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid TumorsLillian L Siu, David S Hong, Wolf-Dietrich Döcke, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2011
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell linesStephan Hailfinger, Hendrik Nogai, Christiane Pelzer, et al.
Pageof 2